We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Suitcase Laboratory Set to Improve Ebolavirus Control

By LabMedica International staff writers
Posted on 19 Jan 2015
A portable laboratory for the diagnosis of Ebolavirus has been developed and the new method is six to ten times faster than the current one, equally sensitive and will be tested in Africa soon.

Currently, laboratory tests for Ebolavirus use a technique called real-time polymerase chain reaction (PCR) that looks for the genome signature of the virus in the sample, and although PCR machines are becoming smaller, they are not suitable for remote locations with no electricity and refrigeration. More...


Scientists at the German Primate Center (DPZ; Göttingen, Germany) have developed Diagnostics-in-a-Suitcase, which contains all reagents and equipment to detect the Ebolavirus within 15 minutes at point-of-need. Moreover, the mobile suitcase laboratory will be operated by an integrated solar panel and a power pack.

The Diagnostics-in-a-Suitcase is based on the Recombinase Polymerase Amplification (RPA) technology developed by TwistDx Ltd. (Cambridge, UK). This method was adapted to be used for Ebolavirus diagnosis by scientists at the University Medical Center Göttingen (Germany). RPA is as sensitive as PCR, but extremely rapid and works at a constant temperature, meaning no rapid heat-cycling equipment is required. Furthermore, reagents used in the RPA test are cold chain independent, which allows them to be used and transported at ambient temperature.

Christiane Stahl-Hennig, DMV, who heads DPZ's Unit of Infection Models, said, “The early detection of Ebola infected patients will lead to a more effective virus control since medical staff can identify and isolate confirmed Ebola cases more rapidly. The Diagnostics-in-a-Suitcase will therefore contribute to a better management during the Ebola-outbreak.” The idea is the Diagnostics-in-a-Suitcase will enable the rapid detection of Ebolavirus not only out in the field but also at other points of need such as airports and quarantine stations.

Related Links:

German Primate Center 
TwistDx Ltd.
University Medical Center Göttingen



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.